Original articleThe yield of active case-finding in persons with inactive pulmonary tuberculosis or fibrotic lesions A 5-year study in tuberculosis clinics in Amsterdam, Rotterdam and Utrecht☆
References (17)
- et al.
Routine follow-up of inactive tuberculosis, a practise to be abandoned
American Review of Respiratory Disease
(1973) - et al.
Epidemiological and clinical study of tuberculosis in the district if Kolin Czechoslovakia
Bulletin of World Health Organization
(1974) - et al.
Surveillance of diagnostic and treatment measures of bacillary pulmonary tuberculosis reported in the Netherlands from 1973 to 1976
Selected Papers
(1982) Epidemiology of tuberculosis and the role of BCG
Clinics in Chest Medicine
(1980)The IUAT trial on isoniazid preventive treatment in persons with fibrotic lesions
Bulletin of International Union Against Tuberculosis
(1975)- et al.
Five years follow-up of the IUAT trial of isoniazid prophylaxis in fibrotic lesions
Bulletin of International Union Against Tuberculosis
(1979) Tuberculosis risk in persons with “fibrotic” X-ray lesions
Bulletin of International Union Against Tuberculosis
(1973)- et al.
Surveillance of diagnostic and treatment measures, Bavaria, 1975
Bulletin of International Union Against Tuberculosis
(1979)
There are more references available in the full text version of this article.
Cited by (9)
Inactive fibrotic lesions versus pulmonary tuberculosis with negative bacteriology
2014, Archivos de BronconeumologiaThoracic and hematogenous tuberculosis in patients aged 75 to 100 years
2016, Gaceta Medica de BilbaoCoverage and yield of entry and follow-up screening for tuberculosis among new immigrants
2008, European Respiratory JournalActive case finding of tuberculosis: Historical perspective and future prospects
2005, International Journal of Tuberculosis and Lung Disease
- ☆
A fuller version of this paper was published in Selected Papers, (K.N.C.V. P.O. Box 146, 2585 GP, The Hague, Netherlands), 22, 5.
- ∗
Dr J. Meijer died on 1 March, 1983.
Copyright © 1984 Published by Elsevier Ltd.